These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2448898)
1. Analogous features of cold-promoted activation and contact system activation in human plasmas: the role of cryptic soluble surfaces in asthma, oral contraception and pregnancy. Freyria AM; Lasser EC; Lyon SG; Simon RA Thromb Res; 1987 Dec; 48(6):729-36. PubMed ID: 2448898 [TBL] [Abstract][Full Text] [Related]
2. Components of the kallikrein-kinin system and the spontaneous cold activation of factor VII in human plasma. Laake K; Gjonnaess H; Fagerhol MK Acta Pharmacol Toxicol (Copenh); 1973; 33(3):229-40. PubMed ID: 4800785 [TBL] [Abstract][Full Text] [Related]
3. Factor VII in plasma of women taking oral contraceptives. Lack of cold activation under blood bank conditions. Seligsohn U; Zivelin A; Zwang E; Bar-Shani S Transfusion; 1984; 24(2):171-2. PubMed ID: 6608809 [TBL] [Abstract][Full Text] [Related]
4. The role of augmented Hageman factor (factor XII) titers in the cold-promoted activation of factor VII and spontaneous shortening of the prothrombin time in women using oral contraceptives. Gordon EM; Ratnoff OD; Jones PK J Lab Clin Med; 1982 Mar; 99(3):363-9. PubMed ID: 7057063 [TBL] [Abstract][Full Text] [Related]
5. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor. Czendlik C; Lämmle B; Duckert F Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997 [TBL] [Abstract][Full Text] [Related]
6. Activation of factors XII and VII induced in citrated plasma in the presence of contact surface. Mitropoulos KA; Martin JC; Stirling Y; Morrisey JH; Cooper JA Thromb Res; 1995 Apr; 78(1):67-75. PubMed ID: 7778067 [TBL] [Abstract][Full Text] [Related]
7. The plasma contact system in atopic asthma. Lasser EC; Lang JH; Curd JG; Cochrane CG; Lyon SG; Howard MM; Hamblin AE; Revak SD J Allergy Clin Immunol; 1983 Jul; 72(1):83-8. PubMed ID: 6189880 [TBL] [Abstract][Full Text] [Related]
8. Initiation of contact system activation in plasma is dependent on factor XII autoactivation and not on enhanced susceptibility of factor XII for kallikrein cleavage. Citarella F; Wuillemin WA; Lubbers YT; Hack CE Br J Haematol; 1997 Oct; 99(1):197-205. PubMed ID: 9359524 [TBL] [Abstract][Full Text] [Related]
9. The activation of the contact phase of coagulation by physiologic surfaces in plasma: the effect of large negatively charged liposomal vesicles. Mitropoulos KA; Martin JC; Reeves BE; Esnouf MP Blood; 1989 May; 73(6):1525-33. PubMed ID: 2713491 [TBL] [Abstract][Full Text] [Related]
10. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives. Norris LA; Bonnar J Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312 [TBL] [Abstract][Full Text] [Related]
11. Primers of contact system activity in asthmatic patients and contrast material reactors. Freyria AM; Lasser EC Invest Radiol; 1988 Sep; 23 Suppl 1():S197-9. PubMed ID: 2461914 [TBL] [Abstract][Full Text] [Related]
12. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. Seligsohn U; Osterud B; Brown SF; Griffin JH; Rapaport SI J Clin Invest; 1979 Oct; 64(4):1056-65. PubMed ID: 479368 [TBL] [Abstract][Full Text] [Related]
13. Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents. Gordon EM; Douglas J; Ratnoff OD J Clin Invest; 1983 Nov; 72(5):1833-8. PubMed ID: 6355187 [TBL] [Abstract][Full Text] [Related]
14. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator. Jespersen J; Kluft C Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350 [TBL] [Abstract][Full Text] [Related]
15. C-1 inactivator and cold-promoted activation of factor VII. van Royen EA; Lohman S; Voss M; Pondman KW J Lab Clin Med; 1978 Aug; 92(2):152-63. PubMed ID: 681808 [TBL] [Abstract][Full Text] [Related]
16. Cold activation of complement and kinin. Kondo M; Takemura S; Yoshikawa T; Kato H; Yokoe N; Ikezaki M; Hosokawa K; Masuda M Adv Exp Med Biol; 1979; 120B():133-8. PubMed ID: 117680 [TBL] [Abstract][Full Text] [Related]
17. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial. Notelovitz M; Kitchens CS; Khan FY Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974 [TBL] [Abstract][Full Text] [Related]
18. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays. Nuijens JH; Huijbregts CC; Cohen M; Navis GO; de Vries A; Eerenberg AJ; Bakker JC; Hack CE Thromb Haemost; 1987 Aug; 58(2):778-85. PubMed ID: 2445044 [TBL] [Abstract][Full Text] [Related]
19. Effect of estrogen treatment on coagulation and fibrinolysis in postmenopausal women. With special reference to cold activation of factor VII. Gjønnaess H; Munkeby I; Frølich W; Vennerød AM; Fagerhol MK Gynecol Obstet Invest; 1978; 9(2-3):109-23. PubMed ID: 738649 [TBL] [Abstract][Full Text] [Related]
20. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy. Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A Popul Sci; 1982; (3):157-68. PubMed ID: 12266214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]